Back to today’s briefing

Story perspectives

Revolutionary Nivolumab Injection Cuts Cancer Treatment Time

5/2/2025

24 2

Left

NHS Revolutionizes Cancer Treatment

NHS England is set to revolutionize cancer treatment with a rapid injectable form of nivolumab, an immunotherapy drug. This breakthrough will benefit up to 15,000 patients each year, allowing them to receive treatment for 15 types of cancer in just 3-5 minutes, drastically cutting down over a year’s worth of treatment time and enhancing patient care.

Right

Dostarlimab Transforms Cancer Care

A groundbreaking clinical trial at Memorial Sloan Kettering Cancer Center has shown that the immunotherapy drug dostarlimab successfully treats 80% of certain solid tumor cancers, eliminating the need for invasive procedures. This revolutionary treatment could spare patients from the grueling effects of surgery, chemotherapy, and radiation, bringing renewed hope and a better quality of life for those battling rectal and other cancers.

1 of 2

NHS Revolutionizes Cancer Treatment

NHS England is set to revolutionize cancer treatment with a rapid injectable form of nivolumab, an immunotherapy drug. This breakthrough will benefit up to 15,000 patients each year, allowing them to receive treatment for 15 types of cancer in just 3-5 minutes, drastically cutting down over a year’s worth of treatment time and enhancing patient care.

1 / 2